Previous close | 277.16 |
Open | 279.63 |
Bid | 286.28 x 800 |
Ask | 284.10 x 900 |
Day's range | 275.49 - 289.45 |
52-week range | 265.00 - 415.73 |
Volume | |
Avg. volume | 625,295 |
Market cap | 20.743B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 40.45 |
EPS (TTM) | 7.04 |
Earnings date | 24 Oct 2024 - 28 Oct 2024 |
Forward dividend & yield | 0.80 (0.29%) |
Ex-dividend date | 31 Jul 2024 |
1y target est | 394.07 |
West Pharmaceutical's (WST) second-quarter results reflect a declining demand for products across its segments amid elevated customer destocking.
West Pharmaceutical (WST) delivered earnings and revenue surprises of -14.12% and 4.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Exton, Pennsylvania-based company said it had profit of $1.51. Earnings, adjusted for amortization costs, were $1.52 per share. The results missed Wall Street expectations.